FERGUSON MARTIN

Ferguson Martin specializes in providing high-level administrative and general management consulting services tailored to complex scientific and clinical research environments. Their core capability centers on delivering subject matter expertise in bioinformatics and cancer genomics, supporting mission-critical programs within federal research institutions. They bring deep domain knowledge in clinical and basic cancer research, assisting agencies in structuring data-driven research initiatives, optimizing bioinformatics workflows, and aligning computational biology efforts with regulatory and scientific standards. Their work emphasizes integration of genomic data systems, analytical pipeline development, and strategic guidance for large-scale research programs, distinguishing them through niche expertise in the intersection of administrative consulting and advanced biomedical science. The contractor has demonstrated direct engagement with the Department of Health and Human Services, particularly in support of the National Cancer Institute’s Center for Cancer Genomics. Their work involves advising on the operational and technical frameworks necessary to advance precision oncology research, suggesting a focused relationship built around mission-critical, science-intensive consulting needs rather than broad administrative support. Their primary NAICS classification, 541611, reflects a specialization in management consulting services for scientific and technical domains, positioning them as a boutique provider for research agencies requiring governance, process optimization, and expert advisory services in genomics and biomedicine. They operate at the intersection of policy, data science, and research administration, serving a highly specialized segment of the federal life sciences market. Ferguson Martin is structured as a small business (2J) based in Stow, Massachusetts. While they currently hold no formal government certifications, their geographic presence in a region rich with biotech and academic research institutions supports their ability to attract and deploy specialized talent. Their market positioning is defined by deep technical consulting in cancer genomics, serving as a trusted advisor to federal research leaders navigating complex scientific infrastructure challenges.